Quarterly report · Q1
2689.TEDINET S100S9PH
Period2023-07-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥27.5bn | 2023-07-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥110.5bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥26.3bn | 2022-07-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥251m | 2023-07-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥403m | 2022-07-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥250m | 2023-07-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.2bn | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥404m | 2022-07-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥250m | 2023-07-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥402m | 2022-07-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥168m | 2023-07-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥251m | 2022-07-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥168m | 2023-07-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥251m | 2022-07-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥41.4bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥40.9bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥38.5bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥31.3bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥30.6bn | at 2023-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥10.0bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥9.0bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.4bn | at 2023-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥27.9 | 2023-07-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥234.9 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.84 | 2022-07-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 24.3% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.3% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.3% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-09-30 | −¥334m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-09-30 | −¥334m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-09-30 | −¥43m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥657m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥656m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥1m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2023-07-01 → 2023-09-30 | ¥56m |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥25.9bn |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥25.6bn |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥299m |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | segment profit | 2023-07-01 → 2023-09-30 | ¥211m |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue | 2023-07-01 → 2023-09-30 | ¥1.3bn |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue external | 2023-07-01 → 2023-09-30 | ¥1.2bn |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥33m |
| jpcrp040300-q1r_E02928-000SPDreportable segment | segment profit | 2023-07-01 → 2023-09-30 | ¥27m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-09-30 | ¥27.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-09-30 | ¥27.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-09-30 | ¥334m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-09-30 | ¥294m |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-09-30 | −¥394m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-09-30 | −¥394m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥38m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥616m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥616m |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥23,000 |
| jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥47m |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥24.8bn |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥24.5bn |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥363m |
| jpcrp040300-q1r_E02928-000Medical Equipmentreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥347m |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q1r_E02928-000SPDreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥32m |
| jpcrp040300-q1r_E02928-000SPDreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥47m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2022-09-30 | ¥26.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2022-09-30 | ¥26.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥394m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2022-09-30 | ¥441m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 347
| Item | Context | Value | Unit |
|---|---|---|---|
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所スタンダード市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)株主としての権利内容に制限のない標準となる株式１単元の株式数 100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Voting rights (text) | FilingDateInstant | Text · Plus | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | Original text (Japanese)１単元（100株）未満の株式 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)オルバヘルスケアホールディングス株式会社 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)岡山県岡山市北区下石井１丁目１番３号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding allowances directly deducted from balances of assets (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | CurrentQuarterInstant | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |